CD33-related siglecs as potential modulators of inflammatory responses

Annals of the New York Academy of Sciences

Volumn 1253, Issue 1, 2012, Pages 102-111

  Crocker, Paul R ^a   McMillan, Sarah J ^a   Richards, Hannah E ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

CD33; Immunoglobulin superfamily; Inhibitory receptors; Innate immunity; Sialic acid; Siglecs

Indexed keywords

CD24 ANTIGEN; CD33 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 12; LECTIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PARACETAMOL; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SIALIC ACID; SIGLEC 8 PROTEIN; SIGLEC PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DENDRITIC CELL; GRANULOCYTE; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER NECROSIS; MACROPHAGE; MEDIATOR; MICROGLIA; MOLECULAR RECOGNITION; MONOCYTE; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84860234082     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06449.x     Document Type: Review

References (78)

1. Crocker, P.R., J.C. Paulson & A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7: 255-266.
2. Angata, T., Y. Tabuchi, K. Nakamura & M. Nakamura. 2007. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution. Glycobiology 17: 838-846.
3. Attrill, H., A. Imamura, R.S. Sharma, et al. 2006. Siglec-7 undergoes a major conformational change when complexed with the alpha(2, 8)-disialylganglioside GT1b. J. Biol. Chem. 281: 32774-32783.
4. Blasius, A.L., M. Cella, J. Maldonado, et al. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107: 2474-2476.
5. Hamerman, J.A., J.R. Jarjoura, M.B. Humphrey, et al. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177: 2051-2055.
6. Cao, H., U. Lakner, B. de Bono, et al. 2008. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur. J. Immunol. 38: 2303-2315.
7. Lock, K., J. Zhang, J. Lu, et al. 2004. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 209: 199-207.
8. Zhang, J.Q., B. Biedermann, L. Nitschke, et al. 2004. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur. J. Immunol. 34: 1175-1184.
9. Floyd, H., J. Ni, A.L. Cornish, et al. 2000. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J. Biol. Chem. 275: 861-866.
10. Kikly, K.K., B.S. Bochner, S.D. Freeman, et al. 2000. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J. Allergy Clin. Immunol. 105: 1093-1100.
11. Zhang, J., A. Raper, N. Sugita, et al. 2006. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107: 3600-3608.
12. Zhang, J.Q., G. Nicoll, C. Jones & P.R. Crocker. 2000. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 275: 22121-22126.
13. Angata, T. & A. Varki. 2000. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 275: 22127-22135.
14. Cornish, A.L., S. Freeman, G. Forbes, et al. 1998. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 92: 2123-2132.
15. Munday, J., S. Kerr, J. Ni, et al. 2001. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem. J. 355: 489-497.
16. Nicoll, G., J. Ni, D. Liu, et al. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274: 34089-34095.
17. Vitale, C., C. Romagnani, M. Falco, et al. 1999. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 96: 15091-15096.
18. Blixt, O., B.E. Collins, I.M. van den Nieuwenhof, et al. 2003. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 278: 31007-31019.
19. Campanero-Rhodes, M.A., R.A. Childs, M. Kiso, et al. 2006. Carbohydrate microarrays reveal sulphation as a modulator of siglec binding. Biochem. Biophys. Res. Commun. 344: 1141-1146.
20. Magesh, S., H. Ando, T. Tsubata, et al. 2011. High-affinity ligands of Siglec receptors and their therapeutic potentials. Curr. Med. Chem. 18: 3537-3550.
21. Cao, H. & P.R. Crocker. 2011. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132: 18-26.
22. O'Reilly, M.K. & J.C. Paulson. 2009. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol. Sci. 30: 240-248.
23. Varki, A. & T. Angata. 2006. Siglecs: the major subfamily of I-type lectins. Glycobiology. 16: 1R-27R.
24. Angata, T., S.C. Kerr, D.R. Greaves, et al. 2002. Cloning and characterization of human Siglec-11. A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J. Biol. Chem. 277: 24466-24474.
25. Avril, T., H. Floyd, F. Lopez, et al. 2004. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J. Immunol. 173: 6841-6849.
26. Avril, T., S.D. Freeman, H. Attrill, et al. 2005. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. J. Biol. Chem. 280: 19843-19851.
27. Freeman, S.D., S. Kelm, E.K. Barber & P.R. Crocker. 1995. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85: 2005-2012.
28. Taylor, V.C., C.D. Buckley, M. Douglas, et al. 1999. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 274: 11505-11512.
29. Orr, S.J., N.M. Morgan, R.J. Buick, et al. 2006. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J. Biol. Chem. 282: 3418-3422.
30. Orr, S.J., N.M. Morgan, J. Elliott, et al. 2006. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood 109: 1061-1068.
31. Boyd, C.R., S.J. Orr, S. Spence, et al. 2009. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J. Immunol. 183: 7703-7709.
32. Ando, M., W. Tu, K. Nishijima & S. Iijima. 2008. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem. Biophys. Res. Commun. 369: 878-883.
33. Ohta, M., A. Ishida, M. Toda, et al. 2010. Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9. Biochem. Biophys. Res. Commun. 402: 663-669.
34. Erickson-Miller, C.L., S.D. Freeman, C.B. Hopson, et al. 2003. Characterization of Siglec-5 (CD170) expression and functional activity of anti-Siglec-5 antibodies on human phagocytes. Exp. Hematol. 31: 382-388.
35. Gunnarsson, P., L. Levander, P. Pahlsson & M. Grenegard. 2007. The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs). FASEB J. 21: 4059-4069.
36. Yamanaka, M., Y. Kato, T. Angata & H. Narimatsu. 2009. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology 19: 841-846.
37. Chen, G.Y., J. Tang, P. Zheng & Y. Liu. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
38. Chen, G.Y., X. Chen, S. King, et al. 2011. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat. Biotechnol. 29: 428-435.
39. Angata, T., T. Hayakawa, M. Yamanaka, et al. 2006. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20: 1964-1973.
40. Schauer, R. & J. Kamerling. 1997. Chemistry, biochemistry and biology of silaic acids. In Glycoproteins II. J. Montreuil, J.F.G. Vliegenthart, & H. Schachter, Eds.: 243-402. Elsevier Science. Amsterdam.
41. Severi, E., D.W. Hood & G.H. Thomas. 2007. Sialic acid utilization by bacterial pathogens. Microbiology 153: 2817-2822.
42. Jones, C., M. Virji & P.R. Crocker. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49: 1213-1225.
43. Wu, C., U. Rauch, E. Korpos, et al. 2009. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J. Immunol. 182: 6508-6516.
44. Avril, T., S.J. North, S.M. Haslam, et al. 2006. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2, 8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2, 8-sialyltransferase gene expression. J. Leukoc. Biol. 80: 787-796.
45. Avril, T., E.R. Wagner, H.J. Willison & P.R. Crocker. 2006. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect. Immun. 74: 4133-4141.
46. Heikema, A.P., M.P. Bergman, H. Richards, et al. 2010. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect. Immun. 78: 3237-3246.
47. Bax, M., M.L. Kuijf, A.P. Heikema, et al. 2011. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect. Immun. 79: 2681-2689.
48. Carlin, A.F., Y.C. Chang, T. Areschoug, et al. 2009. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 206: 1691-1699.
49. Carlin, A.F., A.L. Lewis, A. Varki & V. Nizet. 2007. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 189: 1231-1237.
50. Carlin, A.F., S. Uchiyama, Y.C. Chang, et al. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113: 3333-3336.
51. Erdmann, H., C. Steeg, F. Koch-Nolte, et al. 2009. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell Microbiol. 11: 1600-1611.
52. Gao, P.S., K. Shimizu, A.V. Grant, et al. 2010. Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma. Eur. J. Hum. Genet. 18: 713-719.
53. Nutku, E., H. Aizawa, S.A. Hudson & B.S. Bochner. 2003. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101: 5014-5020.
54. Nutku, E., S.A. Hudson & B.S. Bochner. 2005. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem. Biophys. Res. Commun. 336: 918-924.
55. von Gunten, S., M. Vogel, A. Schaub, et al. 2007. Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J. Allergy. Clin. Immunol. 119: 1005-1011.
56. Zimmermann, N., M.L. McBride, Y. Yamada, et al. 2008. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy 63: 1156-1163.
57. Nutku-Bilir, E., S.A. Hudson & B.S. Bochner. 2008. Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways. Am. J. Respir. Cell Mol. Biol. 38: 121-124.
58. Hudson, S.A., N.V. Bovin, R.L. Schnaar, et al. 2009. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. J. Pharmacol. Exp. Ther. 330: 608-612.
59. von Gunten, S., S. Yousefi, M. Seitz, et al. 2005. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106: 1423-1431.
60. Yousefi, S. & H.U. Simon. 2003. SHP-1: a regulator of neutrophil apoptosis. Semin. Immunol. 15: 195-199.
61. Zhang, M., T. Angata, J.Y. Cho, et al. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109: 4280-4287.
62. Tateno, H., P.R. Crocker & J.C. Paulson. 2005. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology 15: 1125-1135.
63. Dyer, K.D., M. Czapiga, B. Foster, et al. 2007. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. J. Immunol. 179: 1693-1699.
64. Ohnmacht, C., A. Pullner, N. van Rooijen & D. Voehringer. 2007. Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity. J. Immunol. 179: 4766-4774.
65. Bochner, B.S., R.A. Alvarez, P. Mehta, et al. 2005. Glycan array screening reveals a candidate ligand for Siglec-8. J. Biol. Chem. 280: 4307-4312.
66. Cho, J.Y., D.J. Song, A. Pham, et al. 2010. Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13. Respir. Res. 11: 154.
67. Cohn, L., R.J. Homer, A. Marinov, et al. 1997. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186: 1737-1747.
68. Gonzalo, J.A., C.M. Lloyd, L. Kremer, et al. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98: 2332-2345.
69. Sathish, J.G., J. Walters, J.C. Luo, et al. 2004. CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells. J. Biol. Chem. 279: 47783-47791.
70. Yokoi, H., O.H. Choi, W. Hubbard, et al. 2008. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J. Allergy Clin. Immunol. 121: 499-505, e491.
71. Song, D.J., J.Y. Cho, S.Y. Lee, et al. 2009. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J. Immunol. 183: 5333-5341.
72. Song, D.J., J.Y. Cho, M. Miller, et al. 2009. Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin. Immunol. 131: 157-169.
73. Teeling, J.L. & V.H. Perry. 2009. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158: 1062-1073.
74. Dheen, S.T., C. Kaur & E.A. Ling. 2007. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14: 1189-1197.
75. Ransohoff, R.M. & V.H. Perry. 2009. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27: 119-145.
76. Hayakawa, T., T. Angata, A.L. Lewis, et al. 2005. A human-specific gene in microglia. Science 309: 1693.
77. Wang, Y. & H. Neumann. 2010. Alleviation of neurotoxicity by microglial human Siglec-11. J. Neurosci. 30: 3482-3488.
78. Lunnon, K., J.L. Teeling, A.L. Tutt, et al. 2011. Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J. Immunol. 186: 7215-7224.